Table 3 Pooled analysis results of systematic review for each group, based on 910 patients studies
Stage | Sensitivity (95%CI) | Specitivity (95%CI) | Positive LR (95%CI) | Negative LR (95%CI) | DOR (95%CI) | AUROC (95%CI) | Q test, I2 | P value | |
|---|---|---|---|---|---|---|---|---|---|
Sen | Spe | ||||||||
F ≥ 1 | 0.77(0.69–0.83) | 0.90(0.83–0.94) | 7.5(4.4–12.7) | 0.26(0.20–0.35) | 29(15–53) | 0.89(0.86–0.92) | 77.35% | 77.78% | 0.99 |
F ≥ 2 | 0.87(0.74–0.94) | 0.86(0.71–0.94) | 6.2(3.0–12.6) | 0.15(0.08–0.29) | 41(21–81) | 0.93(0.90–0.95) | 84.83% | 90.66% | 0.53 |
F ≥ 3 | 0.89(0.81–0.94) | 0.84(0.63–0.94) | 5.6(2.2–14.2) | 0.13(0.09–0.21) | 42(17–100) | 0.93(0.90–0.95) | 77.40% | 94.85% | 0.72 |
F ≥ 4 | 0.94(0.85–0.98) | 0.75(0.35–0.94) | 3.8(1.1–13.1) | 0.08(0.04–0.16) | 50(16–152) | 0.95(0.93–0.97) | 92.49% | 96.60% | 0.45 |